InvestorsHub Logo
Followers 3
Posts 292
Boards Moderated 0
Alias Born 12/21/2022

Re: Wolverine3 post# 402

Sunday, 06/11/2023 8:47:58 AM

Sunday, June 11, 2023 8:47:58 AM

Post# of 569
Usually, it is a red flag for drug perspectives. Aptose explained it saying that 80 mg dose was partially studied by Hanmi ~3 years ago and patients in 2nd+ line had less options than they have now. Therefore, they were less pre-treated. I guess, FDA was not satisfied by this argument. I think, they are right, because you can bring other explanations which don't look good for Tusp. Not good at all. Therefore, stick to your data.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News